Eli Lilly
LLY
#13
Rank
NZ$1.576 T
Marketcap
NZ$1,758
Share price
3.66%
Change (1 day)
15.33%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

Market capitalization of Eli Lilly (LLY)

Market cap: NZ$1.576 Trillion

As of February 2026 Eli Lilly has a market cap of NZ$1.576 Trillion. This makes Eli Lilly the world's 13th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eli Lilly from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.576 T-5.52%
2025NZ$1.668 T33.58%
2024NZ$1.248 T42.72%
2023NZ$875.03 B59.82%
2022NZ$547.50 B41.53%
2021NZ$386.84 B72.82%
2020NZ$223.83 B19.79%
2019NZ$186.86 B2.41%
2018NZ$182.46 B39.34%
2017NZ$130.94 B11.71%
2016NZ$117.21 B-13.86%
2015NZ$136.07 B39.14%
2014NZ$97.79 B41.09%
2013NZ$69.31 B0.84%
2012NZ$68.73 B11.49%
2011NZ$61.65 B17.8%
2010NZ$52.33 B-7.36%
2009NZ$56.49 B-28.4%
2008NZ$78.89 B-0.21%
2007NZ$79.06 B-5.53%
2006NZ$83.69 B-10.56%
2005NZ$93.56 B3.94%
2004NZ$90.02 B-25.95%
2003NZ$121.57 B-10.73%
2002NZ$136.19 B-35.9%
2001NZ$212.46 B-10.19%
2000NZ$236.58 B70.53%
1999NZ$138.73 B-24.97%
1998NZ$184.90 B38.77%
1997NZ$133.24 B131.67%
1996NZ$57.51 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of Eli Lilly was reported to be:

NZ$1.661 Trillion
by Nasdaq info icon info icon
NZ$1.576 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$960.74 B-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$502.41 B-68.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$257.15 B-83.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$656.14 B-58.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$344.19 B-78.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$193.03 B-87.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$506.04 B-67.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$209.68 B-86.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$497.23 B-68.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$200.82 B-87.26%๐Ÿ‡ฌ๐Ÿ‡ง UK